الفهرس 
Clinical manifestation:
Measures of disease activity and Management of lupusOnly 14 pages are availabe for public view
 |  | from | 184 |  |  |
| | | from | 184 | | |
Abstract
Systemic lupus erythematosus(SLE)is a chronic autoimmune diseass that can affect any organ system of the body Usually, this disease has
remitting relapsing course and it has a tendency to vary from acutely
progressive to chronic indolent forms.
Considering the remitting relapsin nature of most cases of SLE, it it
important to have a biomarker to monitor its disease activity. There are fortunately many validated measure including the Systemic Lupus Activity
Measure, Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Lupus Activity Index, European Consensus Lupus Activity Measurement, and British Isles Lupus Activity Group. These tools have been found to be
beneficial in day to day practice.These validated measurments are confusing, lengthy and time
consuming. However, very recently, platelet indices had been shown to be a very good and easily accessible marker of disease activity in lupus.
This cross-sectional study aimed at evaluating platlet indices as a
reliable predictive marker in measuring disease activity in lupus patients